Greg DeenerChief Executive Officer at iCell Gene TherapeuticsSpeaker
|Greg Deener is CEO of iCell Gene Therapeutics. Greg has had numerous leadership roles at both large corporations (GSK, P&G) as well as earlier stage biotechs (GTx, Sucampo). iCell Gene Therapeutics was founded by Professor Yupo Ma, MD, PhD. Professor Ma is on faculty at Stony Brook as a hematopathologist. iCell began in 2014. The company model is to patent potentially best in class technology (iCell has >100 granted/allowed cell therapy patents), demonstrate the proof of concept in China and then begin full development.